References
- Kang Y, Chen C, Massague J. A self-enabling TGFß response coupled to stress signaling: smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 2003; 11:915-26; PMID:12718878; http://dx.doi.org/10.1016/S1097-2765(03)00109-6
- Yan C, Lu D, Hai T, Boyd DD. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 2005; 24:2425-35; PMID:15933712; http://dx.doi.org/10.1038/sj.emboj.7600712
- Mo P, Wang H, Lu H, Boyd DD, Yan C. MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J Biol Chem 2010; 285:26908-15; PMID:20592017; http://dx.doi.org/10.1074/jbc.M110.132597
- Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, Kennedy K, Hai T, Bolouri H, Aderem A. Systems biology approaches identify ATF3 as a negative regulator of toll-like receptor 4. Nature 2006; 441:173-8; PMID:16688168; http://dx.doi.org/10.1038/nature04768
- Yan C, Boyd DD. ATF3 regulates the stability of p53: a link to cancer. Cell Cycle 2006; 5:926-929; PMID:16628010; http://dx.doi.org/10.4161/cc.5.9.2714
- Wei S, Wang H, Lu C, Malmut S, Zhang J, Ren S, Yu G, Wang W, Tang DD, Yan C. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins. J Biol Chem 2014; 289:8947-59; PMID:24554706; http://dx.doi.org/10.1074/jbc.M113.503755
- Yuan X, Yu L, Li J, Xie G, Rong T, Zhang L, Chen J, Meng Q, Irving AT, Wang D., et al. ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton. Cancer Res 2013; 73:3625-37; PMID:23536558; http://dx.doi.org/10.1158/0008-5472.CAN-12-3879
- Wang H, Jiang M, Cui H, Chen M, Buttyan R, Hayward SW, Hai T, Wang Z, Yan C. The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor. Mol Cell Biol 2012; 32 3190-202; PMID:22665497; http://dx.doi.org/10.1128/MCB.00159-12
- Wang Z, Xu D, Ding H.-F, Kim J, Zhang J, Hai T, Yan C. Loss of ATF3 promotes akt activation and prostate cancer development in a pten knockout mouse model. Oncogene 2014; PMID:25531328; http://dx.doi.org/10.1038/onc.2014.426
- Carverm BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher H., et al. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 2011; 19 575-86; PMID:21575859; http://dx.doi.org/10.1016/j.ccr.2011.04.008